Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 620

1.

UBAP1 mutations cause juvenile-onset hereditary spastic paraplegias (SPG80) and impair UBAP1 targeting to endosomes.

Nan H, Ichinose Y, Tanaka M, Koh K, Ishiura H, Mitsui J, Mizukami H, Morimoto M, Hamada S, Ohtsuka T, Tsuji S, Takiyama Y.

J Hum Genet. 2019 Nov;64(11):1055-1065. doi: 10.1038/s10038-019-0670-9. Epub 2019 Sep 12.

PMID:
31515522
2.

Solving the Thermoelectric Trade-Off Problem with Metallic Carbon Nanotubes.

Ichinose Y, Yoshida A, Horiuchi K, Fukuhara K, Komatsu N, Gao W, Yomogida Y, Matsubara M, Yamamoto T, Kono J, Yanagi K.

Nano Lett. 2019 Oct 9;19(10):7370-7376. doi: 10.1021/acs.nanolett.9b03022. Epub 2019 Sep 9.

PMID:
31498635
3.

Sorting Transition-Metal Dichalcogenide Nanotubes by Centrifugation.

Yomogida Y, Liu Z, Ichinose Y, Yanagi K.

ACS Omega. 2018 Aug 10;3(8):8932-8936. doi: 10.1021/acsomega.8b00745. eCollection 2018 Aug 31.

4.

Is there a gap between health education content and practice toward schistosomiasis prevention among schoolchildren along the shores of Lake Victoria in Kenya?

Takeuchi R, Njenga SM, Ichinose Y, Kaneko S, Estrada CA, Kobayashi J.

PLoS Negl Trop Dis. 2019 Aug 19;13(8):e0007572. doi: 10.1371/journal.pntd.0007572. eCollection 2019 Aug.

5.

Characterization of Vibrio cholerae O1 isolates responsible for cholera outbreaks in Kenya between 1975 and 2017.

Bundi M, Shah MM, Odoyo E, Kathiiko C, Wandera E, Miring'u G, Guyo S, Langat D, Morita K, Ichinose Y.

Microbiol Immunol. 2019 Sep;63(9):350-358. doi: 10.1111/1348-0421.12731. Epub 2019 Aug 12.

PMID:
31407393
6.

Palpebral ptosis as the initial symptom of amyotrophic lateral sclerosis.

Shindo K, Satake A, Fukao T, Ichinose Y, Takiyama Y.

Neurol Sci. 2019 Aug 2. doi: 10.1007/s10072-019-04030-y. [Epub ahead of print] No abstract available.

PMID:
31375937
7.

Long-Term Outcomes of Endovascular Stenting for Blunt Renal Artery Injuries with Stenosis: A Report of Five Consecutive Cases.

Okada I, Inoue J, Kato H, Koido Y, Kiriu N, Hattori T, Morimoto K, Ichinose Y, Yokota H.

J Nippon Med Sch. 2019;86(3):172-178. doi: 10.1272/jnms.JNMS.2019_86-306.

8.

Epidemiology and Pathogenesis of Providencia alcalifaciens Infections.

Shah MM, Odoyo E, Ichinose Y.

Am J Trop Med Hyg. 2019 Aug;101(2):290-293. doi: 10.4269/ajtmh.18-0376.

PMID:
31218997
9.

Pathological findings in a patient with non-dystrophic myotonia with a mutation of the SCN4A gene; a case report.

Hata T, Nagasaka T, Koh K, Tsuchiya M, Ichinose Y, Nan H, Shindo K, Takiyama Y.

BMC Neurol. 2019 Jun 12;19(1):125. doi: 10.1186/s12883-019-1360-0.

10.

Quorum-dependent expression of rsmX and rsmY, small non-coding RNAs, in Pseudomonas syringae.

Nakatsu Y, Matsui H, Yamamoto M, Noutoshi Y, Toyoda K, Ichinose Y.

Microbiol Res. 2019 Jun - Aug;223-225:72-78. doi: 10.1016/j.micres.2019.04.004. Epub 2019 Apr 12.

PMID:
31178054
11.

Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201).

Fukuda M, Kitazaki T, Ogawara D, Ichiki M, Mukae H, Maruyama R, Nakagaki N, Shimada M, Ikeda T, Kishimoto J, Harada T, Seto T, Ebi N, Takayama K, Okamoto I, Ichinose Y, Sugio K.

Lung Cancer. 2019 Jun;132:1-8. doi: 10.1016/j.lungcan.2019.01.008. Epub 2019 Apr 5.

PMID:
31097081
12.

Clinical and Genetic Study of the First Japanese FTDP-17 Patient with a Mutation of +3 in Intron 10 in the MAPT Gene.

Nan H, Takaki R, Shimozono K, Ichinose Y, Koh K, Takiyama Y.

Intern Med. 2019 Aug 15;58(16):2397-2400. doi: 10.2169/internalmedicine.2761-19. Epub 2019 Apr 17.

13.

Glycosidase and glycan polymorphism control hydrolytic release of immunogenic flagellin peptides.

Buscaill P, Chandrasekar B, Sanguankiattichai N, Kourelis J, Kaschani F, Thomas EL, Morimoto K, Kaiser M, Preston GM, Ichinose Y, van der Hoorn RAL.

Science. 2019 Apr 12;364(6436). pii: eaav0748. doi: 10.1126/science.aav0748.

PMID:
30975858
14.

Non-convulsive status epilepticus associated with neuronal intranuclear inclusion disease: A case report and literature review.

Shindo K, Tsuchiya M, Hata T, Ichinose Y, Koh K, Sone J, Nagasaka T, Sobue G, Takiyama Y.

Epilepsy Behav Case Rep. 2019 Jan 26;11:103-106. doi: 10.1016/j.ebcr.2019.01.007. eCollection 2019.

15.

Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.

Sugawara S, Nakagawa K, Yamamoto N, Nokihara H, Ohe Y, Nishio M, Takahashi T, Goto K, Maemondo M, Ichinose Y, Seto T, Sakai H, Gemma A, Imamura F, Shingyoji M, Saka H, Inoue A, Takeda K, Okamoto I, Kiura K, Morita S, Tamura T.

Int J Clin Oncol. 2019 May;24(5):485-493. doi: 10.1007/s10147-019-01396-z. Epub 2019 Mar 4.

16.

Gefitinib Plus Bevacizumab vs. Gefitinib Alone for EGFR Mutant Non-squamous Non-small Cell Lung Cancer.

Kitagawa C, Mori M, Ichiki M, Sukoh N, Kada A, Saito AM, Ichinose Y.

In Vivo. 2019 Mar-Apr;33(2):477-482. doi: 10.21873/invivo.11498.

17.

Loliolide, a Carotenoid Metabolite, Is a Potential Endogenous Inducer of Herbivore Resistance.

Murata M, Nakai Y, Kawazu K, Ishizaka M, Kajiwara H, Abe H, Takeuchi K, Ichinose Y, Mitsuhara I, Mochizuki A, Seo S.

Plant Physiol. 2019 Apr;179(4):1822-1833. doi: 10.1104/pp.18.00837. Epub 2019 Jan 30.

18.

Spinocerebellar ataxia type 31 associated with REM sleep behavior disorder: a case report.

Shindo K, Sato T, Murata H, Ichinose Y, Hata T, Takiyama Y.

BMC Neurol. 2019 Jan 11;19(1):9. doi: 10.1186/s12883-019-1238-1.

19.

Case Report: Bacillus pumilus-Caused Bacteremia in a Patient with Food Poisoning.

Shah MM, Miringu G, Wada A, Kaneko S, Ichinose Y.

Am J Trop Med Hyg. 2019 Mar;100(3):688-690. doi: 10.4269/ajtmh.18-0593.

PMID:
30628569
20.

Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?

Yamaguchi M, Shimamatsu S, Edagawa M, Hirai F, Toyozawa R, Nosaki K, Seto T, Takenoyama M, Ichinose Y.

Surg Today. 2019 Mar;49(3):197-205. doi: 10.1007/s00595-018-1751-7. Epub 2019 Jan 4.

PMID:
30610361
21.

A Japanese family with a novel nonsense mutation in the spastin gene associated with both cerebellar ataxia and cognitive impairment.

Tsuchiya M, Koh K, Ishida A, Ichinose Y, Shindo K, Takiyama Y.

J Neurol Sci. 2019 Feb 15;397:114-116. doi: 10.1016/j.jns.2018.12.025. Epub 2018 Dec 19. No abstract available.

PMID:
30599301
22.

Genomic characterization of uncommon human G3P[6] rotavirus strains that have emerged in Kenya after rotavirus vaccine introduction, and pre-vaccine human G8P[4] rotavirus strains.

Wandera EA, Komoto S, Mohammad S, Ide T, Bundi M, Nyangao J, Kathiiko C, Odoyo E, Galata A, Miring'u G, Fukuda S, Hatazawa R, Murata T, Taniguchi K, Ichinose Y.

Infect Genet Evol. 2019 Mar;68:231-248. doi: 10.1016/j.meegid.2018.12.004. Epub 2018 Dec 10.

PMID:
30543939
23.

Neuroimaging, genetic, and enzymatic study in a Japanese family with a GBA gross deletion.

Ichinose Y, Ishiura H, Tanaka M, Yoshimura J, Doi K, Umeda T, Yamauchi H, Tsuchiya M, Koh K, Yamashiro N, Mitsui J, Goto J, Onishi H, Ohtsuka T, Shindo K, Morishita S, Tsuji S, Takiyama Y.

Parkinsonism Relat Disord. 2019 Apr;61:57-63. doi: 10.1016/j.parkreldis.2018.11.028. Epub 2018 Dec 2.

PMID:
30528172
24.
25.

Correction: PLA2G6-associated neurodegeneration presenting as a complicated form of hereditary spastic paraplegia.

Koh K, Ichinose Y, Ishiura H, Nan H, Mitsui J, Takahashi J, Sato W, Itoh Y, Hoshino K, Tsuji S, Takiyama Y; Japan Spastic Paraplegia Research Consotium.

J Hum Genet. 2019 Jan;64(1):61-63. doi: 10.1038/s10038-018-0533-9.

PMID:
30410098
26.

Novel GARS mutation presenting as autosomal dominant intermediate Charcot-Marie-Tooth disease.

Nan H, Takaki R, Hata T, Ichinose Y, Tsuchiya M, Koh K, Takiyama Y.

J Peripher Nerv Syst. 2019 Mar;24(1):156-160. doi: 10.1111/jns.12289. Epub 2018 Nov 23.

PMID:
30394614
27.

Exome Sequencing Reveals a Novel Homozygous Frameshift Mutation in the CYP7B1 Gene in a Japanese Patient with SPG5.

Nan H, Shimozono K, Ichinose Y, Tsuchiya M, Koh K, Hiraide M, Takiyama Y.

Intern Med. 2019 Mar 1;58(5):719-722. doi: 10.2169/internalmedicine.1839-18. Epub 2018 Oct 17.

28.

PLA2G6-associated neurodegeneration presenting as a complicated form of hereditary spastic paraplegia.

Koh K, Ichinose Y, Ishiura H, Nan H, Mitsui J, Takahashi J, Sato W, Itoh Y, Hoshino K, Tsuji S, Takiyama Y; Japan Spastic Paraplegia Research Consotium.

J Hum Genet. 2019 Jan;64(1):55-59. doi: 10.1038/s10038-018-0519-7. Epub 2018 Oct 9. Erratum in: J Hum Genet. 2018 Nov 9;:.

PMID:
30302010
29.

Perioperative management of laparoscopic surgery in a patient with protein S deficiency complications: A case report.

Tashiro J, Fujii M, Watanabe Y, Ichinose Y, Kudo M, Takenaka Y, Yamasaki K, Masaki Y.

Asian J Endosc Surg. 2019 Jul;12(3):311-314. doi: 10.1111/ases.12649. Epub 2018 Sep 26.

PMID:
30259674
30.

A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L.

Sasaki T, Seto T, Yamanaka T, Kunitake N, Shimizu J, Kodaira T, Nishio M, Kozuka T, Takahashi T, Harada H, Yoshimura N, Tsutsumi S, Kitajima H, Kataoka M, Ichinose Y, Nakagawa K, Nishimura Y, Yamamoto N, Nakanishi Y.

Br J Cancer. 2018 Sep;119(6):675-682. doi: 10.1038/s41416-018-0243-2. Epub 2018 Sep 12.

31.

Specific growth inhibitors of Ralstonia solanacearum, Xanthomonas oryzae pv. oryzae, X. campestris pv. campestris, and Clavibacter michiganensis subsp. michiganensis.

Ombiro GS, Sawai T, Noutoshi Y, Nishina Y, Matsui H, Yamamoto M, Toyoda K, Ichinose Y.

Microbiol Res. 2018 Oct;215:29-35. doi: 10.1016/j.micres.2018.06.005. Epub 2018 Jun 10.

32.

Biosafety and biosecurity capacity building: insights from implementation of the NUITM-KEMRI biosafety training model.

Muriithi B, Bundi M, Galata A, Miringu G, Wandera E, Kathiiko C, Odoyo E, Kamemba M, Amukoye E, Huqa S, Shah M, Inoue S, Ichinose Y.

Trop Med Health. 2018 Aug 8;46:30. doi: 10.1186/s41182-018-0108-7. eCollection 2018.

33.

Novel mutations in the ALDH18A1 gene in complicated hereditary spastic paraplegia with cerebellar ataxia and cognitive impairment.

Koh K, Ishiura H, Beppu M, Shimazaki H, Ichinose Y, Mitsui J, Kuwabara S, Tsuji S, Takiyama Y; Japan Spastic Paraplegia Research Consortium.

J Hum Genet. 2018 Sep;63(9):1009-1013. doi: 10.1038/s10038-018-0477-0. Epub 2018 Jun 18.

PMID:
29915212
34.

A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.

Kogure Y, Saka H, Takiguchi Y, Atagi S, Kurata T, Ebi N, Inoue A, Kubota K, Takenoyama M, Seto T, Kada A, Yamanaka T, Ando M, Yamamoto N, Gemma A, Ichinose Y.

Clin Lung Cancer. 2018 Sep;19(5):e711-e715. doi: 10.1016/j.cllc.2018.05.005. Epub 2018 May 19.

PMID:
29861395
35.

A case of different EGFR mutations in surgically resected synchronous triple lung cancer.

Haratake N, Takenoyama M, Edagawa M, Shimamatsu S, Toyozawa R, Nosaki K, Hirai F, Yamaguchi M, Taguchi K, Seto T, Ichinose Y.

J Thorac Dis. 2018 Apr;10(4):E255-E259. doi: 10.21037/jtd.2018.03.105.

36.

Novel SLC20A2 mutation in primary familial brain calcification with disturbance of sustained phonation and orofacial apraxia.

Nan H, Takaki R, Ichinose Y, Tsuchiya M, Koh K, Hanyu S, Shindo K, Takiyama Y.

J Neurol Sci. 2018 Jul 15;390:1-3. doi: 10.1016/j.jns.2018.03.031. Epub 2018 Mar 27. No abstract available.

PMID:
29801865
37.

High-density lipoprotein suppresses tumor necrosis factor alpha production by mycobacteria-infected human macrophages.

Inoue M, Niki M, Ozeki Y, Nagi S, Chadeka EA, Yamaguchi T, Osada-Oka M, Ono K, Oda T, Mwende F, Kaneko Y, Matsumoto M, Kaneko S, Ichinose Y, Njenga SM, Hamano S, Matsumoto S.

Sci Rep. 2018 Apr 30;8(1):6736. doi: 10.1038/s41598-018-24233-1.

38.

Enhanced AKT Phosphorylation of Circulating B Cells in Patients With Activated PI3Kδ Syndrome.

Asano T, Okada S, Tsumura M, Yeh TW, Mitsui-Sekinaka K, Tsujita Y, Ichinose Y, Shimada A, Hashimoto K, Wada T, Imai K, Ohara O, Morio T, Nonoyama S, Kobayashi M.

Front Immunol. 2018 Apr 5;9:568. doi: 10.3389/fimmu.2018.00568. eCollection 2018.

39.

MexEF-OprN multidrug efflux pump transporter negatively controls N-acyl-homoserine lactone accumulation in pseudomonas syringae pv. Tabaci 6605.

Sawada T, Eguchi M, Asaki S, Kashiwagi R, Shimomura K, Taguchi F, Matsui H, Yamamoto M, Noutoshi Y, Toyoda K, Ichinose Y.

Mol Genet Genomics. 2018 Aug;293(4):907-917. doi: 10.1007/s00438-018-1430-9. Epub 2018 Mar 16.

40.

Intersubband plasmons in the quantum limit in gated and aligned carbon nanotubes.

Yanagi K, Okada R, Ichinose Y, Yomogida Y, Katsutani F, Gao W, Kono J.

Nat Commun. 2018 Mar 16;9(1):1121. doi: 10.1038/s41467-018-03381-y.

41.

Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene.

Kometani T, Sugio K, Osoegawa A, Seto T, Ichinose Y.

Thorac Cancer. 2018 May;9(5):563-570. doi: 10.1111/1759-7714.12616. Epub 2018 Mar 8.

42.

The C-Reactive Protein/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma: A Retrospective Multi-institutional Study.

Takamori S, Toyokawa G, Shimokawa M, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Hirai F, Seto T, Tagawa T, Takenoyama M, Ichinose Y, Maehara Y.

Ann Surg Oncol. 2018 Jun;25(6):1555-1563. doi: 10.1245/s10434-018-6385-x. Epub 2018 Mar 2.

PMID:
29500763
43.

Impact of rotavirus vaccination on rotavirus hospitalisation rates among a resource-limited rural population in Mbita, Western Kenya.

Wandera EA, Mohammad S, Bundi M, Nyangao J, Galata A, Kathiiko C, Odoyo E, Guyo S, Miring'u G, Komoto S, Ichinose Y.

Trop Med Int Health. 2018 Apr;23(4):425-432. doi: 10.1111/tmi.13040. Epub 2018 Mar 8.

44.

Modulation of immune responses by Plasmodium falciparum infection in asymptomatic children living in the endemic region of Mbita, western Kenya.

Kijogi C, Kimura D, Bao LQ, Nakamura R, Chadeka EA, Cheruiyot NB, Bahati F, Yahata K, Kaneko O, Njenga SM, Ichinose Y, Hamano S, Yui K.

Parasitol Int. 2018 Jun;67(3):284-293. doi: 10.1016/j.parint.2018.01.001. Epub 2018 Jan 31.

PMID:
29353010
45.

Sympathetic neurograms showing characteristics of both muscle and skin sympathetic nerve activity in a case with pure autonomic failure.

Shindo K, Satake A, Kurita N, Sato T, Tsuchiya M, Ichinose Y, Hata T, Koh K, Nagasaka T, Takiyama Y.

Clin Auton Res. 2018 Jun;28(3):347-349. doi: 10.1007/s10286-017-0497-4. Epub 2018 Jan 8. No abstract available.

PMID:
29313154
46.

Salicylic acid-dependent immunity contributes to resistance against Rhizoctonia solani, a necrotrophic fungal agent of sheath blight, in rice and Brachypodium distachyon.

Kouzai Y, Kimura M, Watanabe M, Kusunoki K, Osaka D, Suzuki T, Matsui H, Yamamoto M, Ichinose Y, Toyoda K, Matsuura T, Mori IC, Hirayama T, Minami E, Nishizawa Y, Inoue K, Onda Y, Mochida K, Noutoshi Y.

New Phytol. 2018 Jan;217(2):771-783. doi: 10.1111/nph.14849. Epub 2017 Oct 19.

47.

Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer).

Nokihara H, Lu S, Mok TSK, Nakagawa K, Yamamoto N, Shi YK, Zhang L, Soo RA, Yang JC, Sugawara S, Nishio M, Takahashi T, Goto K, Chang J, Maemondo M, Ichinose Y, Cheng Y, Lim WT, Morita S, Tamura T.

Ann Oncol. 2017 Nov 1;28(11):2698-2706. doi: 10.1093/annonc/mdx419.

48.

A typical carcinoid tumor of the lung presenting with pure persistent ground-glass opacity on high-resolution computed tomography: a case report.

Yamaguchi M, Hirai F, Taguchi K, Toyozawa R, Edagawa M, Shimamatsu S, Nosaki K, Seto T, Takenoyama M, Ichinose Y.

Surg Case Rep. 2017 Oct 4;3(1):108. doi: 10.1186/s40792-017-0382-3.

49.

Surgical resection of a well-differentiated inflammatory liposarcoma of the middle mediastinum: a case report.

Edagawa M, Haratake N, Shimamatsu S, Toyozawa R, Nosaki K, Hirai F, Yamaguchi M, Taguchi K, Kaneko K, Seto T, Takenoyama M, Ichinose Y.

J Thorac Dis. 2017 Aug;9(8):E689-E693. doi: 10.21037/jtd.2017.07.90.

50.

A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.

Saka H, Kitagawa C, Ichinose Y, Takenoyama M, Ibata H, Kato T, Takami K, Yamashita M, Maeda T, Takeo S, Ueda H, Okabayashi K, Nagashima S, Oka T, Kouso H, Fukuyama S, Yoshimoto K, Shimokawa M, Saito AM, Ito S.

Trials. 2017 Sep 15;18(1):429. doi: 10.1186/s13063-017-2103-4.

Supplemental Content

Loading ...
Support Center